A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Christine Poulos
Senior Economist and Global Head, Health Preference Assessment
William L Herring
Senior Director, Health Economics
Cynthia Macahilig
Executive Vice President, Research Operations, MDA
Keith Davis
Senior Director, Health Economics
Ryan Ziemiecki
Director, Biostatistics
Colleen Castro
Associate Director, Market Access and Outcomes Strategy
Chris Knight
Senior Director, Health Economics
Dee Dee Mladsi (she/her)
Head, Health Economics—Strategy and Early Modeling
Katherine Hicks
Director, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Anita Brogan
Head, Decision Analytic Modeling, Health Economics
Marci Clark
Director, Patient-Centered Outcomes Assessment
Dawn Odom
Vice President, Biostatistics
Xiaolei Zhou
Director, Biostatistics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Jonathan Graham
Director, Health Economics
Michele Wilson
Senior Director, Health Economics
Jianmin Wang
Senior Statistician, Biostatistics
Caroline Ling
Senior Director and HTA Specialist, Market Access and Outcomes Strategy
James Kaye
Senior Director, Epidemiology
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Bintu Sherif
Director, Biostatistics
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Beth Sherrill
Vice President, Biostatistics
Katherine Stull
Director, Health Economics
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Costel Chirila
Director, Biostatistics
Alicia Gilsenan
Senior Director and Head, Epidemiology
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Elizabeth B. Andrews
Vice President, Emeritus, Epidemiology
Kelly Hollis
Vice President, Surveys and Observational Studies
Christopher Graham
Senior Director, Health Economics
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
Annete Njue
Director, Market Access and Outcomes Strategy
Kenneth J Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Juliana Meyers
Director, Health Economics
Sean Candrilli
Vice President, Health Economics
Mark Price
Senior Director, Health Economics
Stephanie Barrows
Executive Director, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Lia Gutierrez
Senior Director, Epidemiology
Joan Fortuny
Director, Epidemiology
Marco Boeri
Senior Economist

Selected Recent Oncology Publications

Arana A, Pottegard A, Kuiper JG, Crellin E, Reutfors J, Schmitt-Egenolf M, Lund LC, Houben E, Booth H, Calingaert B, Kaye JA, Gembert K, Rothman KJ, Dedman D, Kieler H, Gutierrez L, Hallas J, Perez-Gutthann S. To what extent are topical tacrolimus or pimecrolimus associated with an increased risk of skin cancer and lymphoma? Long-term results from JOELLE study. Poster to be given at the 2020 Virtual European Academy of Dermatology and Venereology Conference; October 29, 2020. Previously presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management.